Nicht muskelinvasives Harnblasenkarzinom: Risikostratifizierung und Befundweitergabe
详细信息 查看全文
- 作者：Dr. S. Lebentrau ; M. May ; D. Weckermann ; T. Speck ; A.-K. Wick ; M. Mathew…
- 关键词：SchlüsselwörterNMIBC ; Leitlinie ; Risikostratifizierung ; Untertherapie ; Fragebogen
- 刊名：Der Urologe
- 出版年：2017
- 出版时间：February 2017
- 年：2017
- 卷：56
- 期：2
- 页码：194-201
- 全文大小：
- 刊物类别：Medicine
- 刊物主题：Urology;
- 出版者：Springer Medizin
- ISSN：1433-0563
- 卷排序：56
文摘
Background and objectivesThe adjuvant treatment of non-muscle-invasive bladder cancer (NMIBC) is based on the individual risk profile (RP) and its sufficient transfer from the clinic to the doctor’s office. The objectives of our study were to verify the importance and degree of transfer of RP and recommendation for risk-adapted adjuvant treatment (RAAT) in patients with NMIBC as well as to develop appropriate tools for this purpose, if necessary.